Otis Worldwide Corp.
Congress has disclosed 13 buys and 10 sells of OTIS (Otis Worldwide Corp.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Round-trip watch Still on the books
Members who disclosed buying OTIS and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| William Keating | 2026-04-29 | $75.68 | $75.75 | +0.1% | ↩ near entry |
| Alan Armstrong | 2026-03-27 | $75.04 | $75.75 | +0.9% | ↩ near entry |
| John Boozman | 2026-08-27 | $71.48 | $75.75 | +6.0% | ↩ near entry |
| Rohit Khanna | 2026-06-02 | $69.91 | $75.75 | +8.4% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Technology. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
Legislation Related Legislation
Recent bills in this stock's sector (Technology). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 7022 | Mystic Alerts Act | Science, Technology, Communications | 2026-10-22 |
| S 5663 | PROOF Act | Science, Technology, Communications | 2026-09-30 |
| SRES 923 | A resolution expressing support for the designation of October 4 through October 10, 2026, as "National 4-H Week". | Science, Technology, Communications | 2026-09-29 |
| HR 10610 | Stop Spam Calls Act | Science, Technology, Communications | 2026-09-24 |
| HR 10594 | Reliable Artificial Intelligence Research Act of 2026 | Science, Technology, Communications | 2026-09-24 |
27 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| John Boozman | Senate | BUY | Joint | 2026-08-27 | 15 days | -3.3% | $1K–$15K | 96.9 | ↗ eFD |
| Kevin Hern | House | SELL | Joint · Hern Family Revocable Trust | 2026-08-10 | 17 days | -1.3% | $1K–$15K 0.1% of NW |
85.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2026-06-02 | 29 days | +0.4% | $1K–$15K | 19.9 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2026-05-01 | 38 days | -9.1% | $1K–$15K | 31.1 | ↗ filing |
| William Keating | House | BUY ◆ insider divergence | Self · Bill's IRA | 2026-04-29 | 5 days | -0.9% | $1K–$15K 0.3% of NW |
69.8 | ↗ filing |
| Alan Armstrong | Senate | BUY ◆ insider divergence · moderate | Self | 2026-03-27 | 116 days | -4.7% | $1K–$15K | 82.9 | ↗ eFD |
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-31 | 1 days | 0.0% | $1K–$15K 0.1% of NW |
7.8 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-10-30 | 2 days | +0.3% | $1K–$15K 0.1% of NW |
28.1 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab 401K > Schwab 893 | 2025-10-30 | 2 days | +0.3% | $1K–$15K 0.1% of NW |
28.1 | ↗ filing |
| Lisa McClain | House | BUY | Spouse · Charles Schwab Brokerage Account 924 | 2025-08-04 | 9 days | +4.5% | $1K–$15K 0.1% of NW |
66.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR | Child | 2025-07-25 | 7 days | -5.4% | $1K–$15K | 32.3 | ↗ filing |
| Ritchie John Torres | House | SELL | Self | 2025-07-11 | 21 days | -14.6% | $1K–$15K 3.2% of NW 🔥 |
54.2 | ↗ filing |
| Thomas Tuberville | Senate | OTHER | Joint | 2024-10-29 | 645 days | -25.5% | $1K–$15K | 75.9 | ↗ eFD |
| Thomas Tuberville | Senate | OTHER | Joint | 2024-10-29 | 645 days | -25.5% | $1K–$15K | 75.9 | ↗ eFD |
| Ritchie John Torres | House | BUY ◆ insider divergence | Self | 2024-09-26 | 309 days | -16.8% | $1K–$15K 3.2% of NW 🔥 |
85.0 | ↗ filing |
| John James | House | SELL | Self · John A. James Children’s Trust | 2024-09-04 | 1 days | -1.9% | $1K–$15K <0.1% of NW |
26.0 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2024-01-10 | 23 days | — | $1K–$15K | 40.4 | ↗ filing |
| John James | House | BUY | Self · John A. James Children’s Trust | 2023-11-10 | 277 days | — | $1K–$15K <0.1% of NW |
86.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR | Child | 2023-11-03 | 32 days | — | $1K–$15K | 86.8 | ↗ filing |
| Pete Sessions | House | SELL | Self | 2022-01-18 | 24 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Debbie Dingell | House | SELL | Self | 2021-06-18 | 3 days | — | $15K–$50K 0.3% of NW |
56.6 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2020-09-23 | 14 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Michael Conaway | House | SELL | Self | 2020-05-19 | 3 days | — | $1K–$15K | 86.8 | ↗ filing |
| David McKinley | House | SELL | Joint | 2020-04-24 | 6 days | — | $1K–$15K | 52.4 | ↗ filing |
| David McKinley | House | SELL | Self | 2020-04-13 | 17 days | — | $1K–$15K | 75.9 | ↗ filing |
| David Price | House | EXCHANGE | Self | 2020-04-07 | 30 days | — | $1K–$15K | 86.8 | ↗ filing |
| Debbie Dingell | House | EXCHANGE | Self | 2020-04-03 | 3 days | — | $1K–$15K 0.1% of NW |
86.8 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in OTIS — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in OTIS, 2 coincided with corporate insiders moving the same way within 60 days, and 7 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-05-07 | Lefebure Thibault Pierre Marie | C-suite | SELL | $125K | ↗ EDGAR |
| 2026-02-12 | de Montlivault Stephane | C-suite | SELL | $4.4M | ↗ EDGAR |
| 2026-02-10 | LaFreniere Nora E. | Other | SELL | $162K | ↗ EDGAR |
| 2026-02-10 | LaFreniere Nora E. | Other | SELL | $2.3M | ↗ EDGAR |
| 2026-02-10 | Ryan Michael Patrick | Other | SELL | $106K | ↗ EDGAR |
| 2026-02-05 | Marks Judith Fran | C-suite | SELL 10b5-1 | $5.1M | ↗ EDGAR |
| 2026-02-04 | Marks Judith Fran | C-suite | SELL 10b5-1 | $4.2M | ↗ EDGAR |
| 2026-02-02 | Green Neil | C-suite | SELL | $519K | ↗ EDGAR |
| 2025-11-05 | Ryan Michael Patrick | Other | SELL | $278K | ↗ EDGAR |
| 2025-03-10 | de Montlivault Stephane | C-suite | SELL | $382K | ↗ EDGAR |
| 2025-03-10 | de Montlivault Stephane | C-suite | SELL | $320K | ↗ EDGAR |
| 2025-02-13 | de Montlivault Stephane | C-suite | SELL | $2.4M | ↗ EDGAR |
| 2025-02-10 | LaFreniere Nora E. | Other | SELL | $163K | ↗ EDGAR |
| 2025-02-10 | Marks Judith Fran | C-suite | SELL 10b5-1 | $2.7M | ↗ EDGAR |
| 2025-02-05 | Marks Judith Fran | C-suite | SELL 10b5-1 | $3.6M | ↗ EDGAR |
| 2025-02-05 | LaFreniere Nora E. | Other | SELL | $451K | ↗ EDGAR |
| 2025-01-31 | Zheng Peiming | C-suite | SELL | $1.7M | ↗ EDGAR |
| 2025-01-31 | Zheng Peiming | C-suite | SELL | $1.5M | ↗ EDGAR |
| 2024-11-08 | Ryan Michael Patrick | Other | SELL | $569K | ↗ EDGAR |
| 2024-11-07 | Luersman Abbe | Other | SELL | $909K | ↗ EDGAR |
| 2024-05-07 | Zheng Peiming | C-suite | SELL | $2.8M | ↗ EDGAR |
| 2024-02-21 | de Montlivault Stephane | C-suite | SELL | $1.7M | ↗ EDGAR |
| 2024-02-20 | Ryan Michael Patrick | Other | SELL | $320K | ↗ EDGAR |
| 2024-02-20 | LaFreniere Nora E. | Other | SELL | $2.0M | ↗ EDGAR |
| 2024-02-07 | Marks Judith Fran | C-suite | SELL 10b5-1 | $3.4M | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| Congress | 2026-08-27 | John Boozman | BUY | $1K–$15K |
| Congress | 2026-08-10 | Kevin Hern | SELL | $1K–$15K |
| Congress | 2026-06-02 | Rohit Khanna | BUY | $1K–$15K |
| ◆ insider | 2026-05-07 | Lefebure Thibault Pierre Marie C-suite | SELL | $125K |
| Congress | 2026-05-01 | Rohit Khanna | BUY | $1K–$15K |
| Congress | 2026-04-29 | William Keating | BUY | $1K–$15K |
| Congress | 2026-03-27 | Alan Armstrong | BUY | $1K–$15K |
| ◆ insider | 2026-02-12 | de Montlivault Stephane C-suite | SELL | $4.4M |
| ◆ insider | 2026-02-10 | LaFreniere Nora E. Other | SELL | $162K |
| ◆ insider | 2026-02-10 | LaFreniere Nora E. Other | SELL | $2.3M |
| ◆ insider | 2026-02-10 | Ryan Michael Patrick Other | SELL | $106K |
| ◆ insider | 2026-02-05 | Marks Judith Fran C-suite 10b5-1 | SELL | $5.1M |
| ◆ insider | 2026-02-04 | Marks Judith Fran C-suite 10b5-1 | SELL | $4.2M |
| ◆ insider | 2026-02-02 | Green Neil C-suite | SELL | $519K |
| ◆ insider | 2025-11-05 | Ryan Michael Patrick Other | SELL | $278K |
| Congress | 2025-10-31 | Lisa McClain | SELL | $1K–$15K |
| Congress | 2025-10-30 | Lisa McClain | SELL | $1K–$15K |
| Congress | 2025-10-30 | Lisa McClain | BUY | $1K–$15K |
| Congress | 2025-08-04 | Lisa McClain | BUY | $1K–$15K |
| Congress | 2025-07-25 | Rohit Khanna | BUY | $1K–$15K |
| Congress | 2025-07-11 | Ritchie John Torres | SELL | $1K–$15K |
| ◆ insider | 2025-03-10 | de Montlivault Stephane C-suite | SELL | $382K |
| ◆ insider | 2025-03-10 | de Montlivault Stephane C-suite | SELL | $320K |
| ◆ insider | 2025-02-13 | de Montlivault Stephane C-suite | SELL | $2.4M |
FAQ Common questions
How much has Congress traded OTIS?
13 disclosed buys and 10 sells of OTIS (Otis Worldwide Corp.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade OTIS?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.